Samrat Pharmachem Ltd share price logo

Samrat Pharmachem Ltd Share Price (530125)

Check the latest share price of Samrat Pharmachem Ltd, along with the price target, peer comparison, quarterly results, recent news, expert analysis, shareholding pattern, and other key fundamentals to make informed investment decisions.

₹3411.46%

as on 04:01PM, 20 Jun 2025

BSE

bell
The current prices are delayed by 15 mins, login to check live prices.

Samrat Pharmachem Ltd Stock Performance

Get live Samrat Pharmachem Ltd share price, day's high and low, historical returns, and market stats.

  • Day's Low

    Day's High

    ₹340
    Day's Price Range
    ₹348.9
  • 52 Week's Low

    52 Week's High

    ₹302.05
    52-Week Price Range
    ₹646
1 Month Return-9.96 %
3 Month Return+ 5.24 %
1 Year Return-3.97 %
3 Year Return-11.17 %
5 Year Return+ 369.79 %
Previous Close₹336.10
Open₹340.00
Volume364.00
Upper Circuit₹403.30
Lower Circuit₹268.90

Samrat Pharmachem Ltd Fundamentals & Key Indicators

Check Samrat Pharmachem Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

₹105.45 Cr

Return on Equity (ROE)

3.37

PE Ratio (TTM)

0

Return on capital employed (ROCE)

4.14

Beta (LTM)

0.64

P/B Ratio

1.59

Dividend Yield

0

PEG Ratio

0

Quarterly Earnings Growth YOY

-128.57

EPS (TTM)

0

Sector

Pharmaceuticals

Book Value

0

Technical Analysis

How to invest in Samrat Pharmachem Ltd?

Investing in Samrat Pharmachem Ltd is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Samrat Pharmachem Ltd or 530125 on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

For example: You can buy 10 shares of Samrat Pharmachem Ltd or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Samrat Pharmachem Ltd with just a few clicks!

Samrat Pharmachem Ltd Stock's Interest Amongst Investors

-36%

Period Jun 22, 2025 to May 23, 2025. Change in 30 Days vs previous period

Search interest for Samrat Pharmachem Ltd Stock has decreased by -36% in the last 30 days, reflecting a downward trend in search activity.

Samrat Pharmachem Ltd Financial Results

Get the annual and quarterly financial summary of Samrat Pharmachem Ltd, including revenue, profit, loss and more.

Value in ₹ crore
DetailsQ4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25
Revenue

(in ₹ Cr)

83 (0%)81 (2%)70 (13%)64 (9%)71 (12%)
Net Income

(in ₹ Cr)

1 (0%)2 (48%)3 (28%)3 (5%)-0 (114%)
Net Profit Margin1.69% (0%)2.56% (51%)3.79% (48%)4.37% (15%)-0.56% (113%)
Value in ₹ crore
DetailsFY21FY22FY23FY24
Total Assets

(in ₹ Cr)

57 (0%)85 (47%)117 (38%)122 (4%)
Total Liabilities

(in ₹ Cr)

28 (0%)38 (36%)54 (42%)57 (6%)
Value in ₹ crore
DetailsFY20FY21FY22FY23FY24
Operating Cash Flow

(in ₹ Cr)

-1 (0%)5 (461%)17 (264%)-9 (154%)9 (200%)

Samrat Pharmachem Ltd Earnings and Dividends

View detailed summary of the earnings and dividend history of Samrat Pharmachem Ltd.

  • Samrat Pharmachem Ltd Earnings Results

    Samrat Pharmachem Ltd’s net profit fell -128.57% since last year same period to ₹0.40Cr in the Q4 2024-2025. On a quarterly growth basis, Samrat Pharmachem Ltd has generated -114.39% fall in its net profits since last 3-months.

    Read More about Earnings Results
  • Samrat Pharmachem Ltd Dividends May,2024

    In the quarter ending March 2024, Samrat Pharmachem Ltd has declared dividend of ₹1 - translating a dividend yield of 0.59%.

    Read More about Dividends

Samrat Pharmachem Ltd Shareholding Pattern

View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Samrat Pharmachem Ltd.

InvestorsHoldings %Quarterly Trend3M change
Promoter Holdings
49.09%
0.00
Foreign Institutions
0%
0.00
Mutual Funds
0%
0.00
Retail Investors
47.67%
0.00
Others
3.24%
0.00

Samrat Pharmachem Ltd vs Peers

Compare market cap, revenue, PE, and other key metrics of Samrat Pharmachem Ltd with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
NA105.4573.96%0.562281
NA77.9745.54%0.50NA6
BUY22,153.8649.69%0.753972,056
BUY15,548.9592.89%0.504611,694
NA1,824.62-1.71%0.6257398

Samrat Pharmachem Ltd News & Key Events

Latest news and events in one place to help you make informed investing decisions in Samrat Pharmachem Ltd.

  • Samrat Pharma Reports Decline in Sales and Losses - 10 Jun, 2025

    Samrat Pharma's standalone net sales for March 2025 fell by 13.88% year-on-year to Rs 71.20 crore. The company reported a net loss of Rs 0.40 crore, a significant decrease from the previous year's loss. EBITDA also dropped by 98.79%. The stock closed at Rs 348.25, reflecting a -14.70% return over the last six months.

Insights on Samrat Pharmachem Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 49.09% of holdings in Mar 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 45.8% return, outperforming this stock by 49.7%

  • imgNO EFFECT

    Retail Holding Unchanged

    img

    Retail Investor holdings remained unchanged at 47.67% of holdings in Mar 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 124.3% return, outperforming this stock by 135.5%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, Samrat Pharma stock has moved down by -10.0%

About Samrat Pharmachem Ltd

Samrat Pharmachem Ltd is a chemical manufacturing company established in 1992 with its headquarters in India. Over the years, the company has successfully diversified and branched out into pharmaceuticals and pharmaceutical bulk drugs by forming a new 100% subsidiary, Samrat Remedies Limited, in 2003. Samrat Remedies Limited is exclusively devoted to the manufacturing of pharmaceutical bulk drugs and chemicals. Samrat Pharmachem Ltd prides itself on offering customers with premium products and superior quality services along with its commitment to innovation to find solutions for the world's toughest problems.

Revenue: ₹71.20Cr as on March 2025 (Q4 FY25)
Net Profit: ₹0.40Cr as on March 2025 (Q4 FY25)
Chairperson Name: Lalit Mehta
OrganisationSamrat Pharmachem Ltd
HeadquartersMumbai
IndustryPharmaceuticals
CEOLalit Mehta
E-voting on sharesClick here to vote

FAQs

What is Samrat Pharmachem Ltd share price today?

Samrat Pharmachem Ltd share price today stands at ₹341, Open: ₹340, Previous Close: ₹336.1, High: ₹348.9, Low: ₹340, 52 Week High: ₹646, 52 Week Low: ₹302.05.

What is today's traded volume of Samrat Pharmachem Ltd?

Today's traded volume of Samrat Pharmachem Ltd is 364.00. Which means that 364.00 shares of Samrat Pharmachem Ltd were bought and sold on the stock market during today's trading session.

What is Samrat Pharmachem Ltd's market cap today?

Today's market capitalisation of Samrat Pharmachem Ltd is ₹105.45 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.

What is the 52 week high and 52 week low range of Samrat Pharmachem Ltd?

Samrat Pharmachem Ltd’s 52 week high is ₹646 and 52 week low is ₹302.05. The current share price of Samrat Pharmachem Ltd is ₹341, which is -47.21% down from its 52 week high and 12.90% up from its 52 week low.